| Dr Andrew Jacob Hale, MD | |
|
111 Colchester Ave, Burlington, VT 05401-1473 | |
| (802) 847-4594 | |
| (802) 847-9783 |
| Full Name | Dr Andrew Jacob Hale |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 13 Years |
| Location | 111 Colchester Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245525823 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 287981 (New York) | Secondary |
| 207RI0200X | Internal Medicine - Infectious Disease | 042.0013754 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
The budget plan, developed by House Budget Committee Chairman Paul Ryan, R- Wis., targets a number of Obama administration domestic initiatives. It trims an estimated $261 billion in domestic spending over the next decade and undoes elements of the health law.
A clinical trial using an all-natural lozenge to treat dry mouth, a condition that impacts 40 percent of American adults, is under way at Georgia Health Sciences University College of Dental Medicine.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
In future patients in the UK will be able to see a GP in the evenings and at weekends.
› Verified 4 days ago
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
The budget plan, developed by House Budget Committee Chairman Paul Ryan, R- Wis., targets a number of Obama administration domestic initiatives. It trims an estimated $261 billion in domestic spending over the next decade and undoes elements of the health law.
A clinical trial using an all-natural lozenge to treat dry mouth, a condition that impacts 40 percent of American adults, is under way at Georgia Health Sciences University College of Dental Medicine.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
In future patients in the UK will be able to see a GP in the evenings and at weekends.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew Jacob Hale, MD 111 Colchester Avenue, Uvm Medical Center - Div. Of Infectious Disease, Burlington, VT 05401 Ph: (802) 847-4594 | Dr Andrew Jacob Hale, MD 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-4594 |
News Archive
The budget plan, developed by House Budget Committee Chairman Paul Ryan, R- Wis., targets a number of Obama administration domestic initiatives. It trims an estimated $261 billion in domestic spending over the next decade and undoes elements of the health law.
A clinical trial using an all-natural lozenge to treat dry mouth, a condition that impacts 40 percent of American adults, is under way at Georgia Health Sciences University College of Dental Medicine.
Regeneron Pharmaceuticals, Inc. and Sanofi announced today that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo.
In future patients in the UK will be able to see a GP in the evenings and at weekends.
› Verified 4 days ago
Nadia Ghallab, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Beach Conger, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 617 Riverside Ave, Burlington, VT 05401 Phone: 802-864-6309 Fax: 802-860-4313 | |
Dr. Christopher Dwight Huston, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-2264 | |
Beth Diane Kirkpatrick, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Fletcher Allen Health Care, Burlington, VT 05401 Phone: 802-847-4594 | |
Dr. Richard Frank Branda, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1 S. Prospect St, Burlington, VT 05401 Phone: 802-847-3827 Fax: 802-847-3510 | |
Lauren Suggs, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Magdalena Anna Zeglin, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 |